|
Volumn 14, Issue 1, 2007, Pages
|
Drugs in pregnancy: Acknowledging challenges - Finding solutions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABC TRANSPORTER;
ANTIDIABETIC AGENT;
BENDECTIN;
BREAST CANCER RESISTANCE PROTEIN;
CITALOPRAM;
CYTOCHROME P450;
FLUOXETINE;
GLIBENCLAMIDE;
INSULIN;
MULTIDRUG RESISTANCE PROTEIN 3;
NICOTINE;
PLACEBO;
PROTEINASE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
SULFONYLUREA;
BLOOD PLACENTA BARRIER;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
DIET THERAPY;
DRUG BLOOD LEVEL;
DRUG DISPOSITION;
DRUG HALF LIFE;
DRUG MANUFACTURE;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
FETAK HYPERINSULINISM;
FETUS CIRCULATION;
FETUS RISK;
HUMAN;
HYPERINSULINISM;
HYPOGLYCEMIA;
INSULIN TREATMENT;
MATERNAL CARE;
MEDICAL ETHICS;
MEDICAL PRACTICE;
NEWBORN HYPOGLYCEMIA;
NICOTINE REPLACEMENT THERAPY;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PREGNANCY;
PREGNANCY DIABETES MELLITUS;
PREGNANCY OUTCOME;
PRENATAL EXPOSURE;
PUERPERAL DEPRESSION;
RANDOMIZED CONTROLLED TRIAL;
THIRD TRIMESTER PREGNANCY;
UMBILICAL CORD BLOOD;
|
EID: 33846683295
PISSN: 1198581X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (5)
|
References (7)
|